0001104659-20-033114.txt : 20200313
0001104659-20-033114.hdr.sgml : 20200313
20200313160745
ACCESSION NUMBER: 0001104659-20-033114
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200101
FILED AS OF DATE: 20200313
DATE AS OF CHANGE: 20200313
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lorenz Kevin
CENTRAL INDEX KEY: 0001772558
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35366
FILM NUMBER: 20712703
MAIL ADDRESS:
STREET 1: C/O NUVEEN
STREET 2: 333 W. WACKER DR.
CITY: CHICAGO
STATE: IL
ZIP: 60606
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Fortress Biotech, Inc.
CENTRAL INDEX KEY: 0001429260
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 205157386
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2 GANSEVOORT STREET
STREET 2: 9TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10014
BUSINESS PHONE: 781-652-4500
MAIL ADDRESS:
STREET 1: 2 GANSEVOORT STREET
STREET 2: 9TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10014
FORMER COMPANY:
FORMER CONFORMED NAME: CORONADO BIOSCIENCES INC
DATE OF NAME CHANGE: 20080310
4
1
tm2011481-5_form4.xml
FORM 4
X0306
4
2020-01-01
0
0001429260
Fortress Biotech, Inc.
FBIO
0001772558
Lorenz Kevin
C/O FORTRESS BIOTECH, INC.
2 GANSEVOORT STREET, 9TH FLOOR
NEW YORK
NY
10014
1
0
0
0
COMMON STOCK, PAR VALUE $0.001
2020-01-01
4
P
0
50000
0.00
A
164582
D
One-third of the shares will vest on each of January 1, 2021, 2022 and 2023, subject to continued service.
Includes 34,582 shares owned by Mr. Lorenz prior to his appointment to the Company's board in August 2019.
/s/ Samuel Berry / Attorney-in-Fact
2020-03-13